151409-79-9 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 17 carbon (C) atoms, 15 hydrogen (H) atoms, 1 nitrogen (N) atom, and 1 oxygen (O) atom.
Explanation
This structure describes the arrangement of atoms and the type of chemical bonds between them. It is an aldehyde derivative of indole, which is a heterocyclic aromatic organic compound.
Explanation
The compound contains an aldehyde group (-CHO), an indole ring, and a methylphenyl group (-C6H4-CH3) attached to the indole.
Explanation
The indole ring in the molecule is aromatic, meaning it has a planar structure with delocalized π-electrons, which contributes to its stability and unique chemical properties.
Explanation
The compound is used as a starting material or intermediate in the synthesis of other organic compounds, particularly in the pharmaceutical and chemical industries.
Explanation
Due to its unique chemical structure and properties, the compound has potential applications in the field of organic chemistry and drug discovery. It can also be used in various other industries, making it a versatile and important chemical compound.
Explanation
The solubility of the compound in different solvents is not mentioned in the material provided. However, it is generally expected to be soluble in organic solvents like ethanol, methanol, or acetone, and less soluble in water.
Explanation
The stability of the compound under various conditions (e.g., temperature, pH, light exposure) is not mentioned in the material provided. However, as an aromatic compound, it is generally expected to be stable under normal conditions.
Explanation
The reactivity of the compound with other chemicals or functional groups is not mentioned in the material provided. However, the presence of the aldehyde group suggests that it may be reactive with reducing agents, oxidizing agents, and nucleophiles.
Chemical Structure
1-[(4-METHYLPHENYL)METHYL]-1H-INDOLE-3-CARBALDEHYDE
Functional Groups
Aldehyde, Indole, and Methylphenyl
Aromaticity
Hetrocyclic aromatic compound
Pharmaceutical and Chemical Industries
Synthesis of various organic compounds and building block in drug production
Applications
Organic chemistry, drug discovery, and potential uses in different industries
Solubility
Not specified in the material provided
Stability
Not specified in the material provided
Reactivity
Not specified in the material provided
Check Digit Verification of cas no
The CAS Registry Mumber 151409-79-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,4,0 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 151409-79:
(8*1)+(7*5)+(6*1)+(5*4)+(4*0)+(3*9)+(2*7)+(1*9)=119
119 % 10 = 9
So 151409-79-9 is a valid CAS Registry Number.
InChI:InChI=1/C17H15NO/c1-13-6-8-14(9-7-13)10-18-11-15(12-19)16-4-2-3-5-17(16)18/h2-9,11-12H,10H2,1H3
151409-79-9Relevant articles and documents
Synthesis, antimycobacterial and anticancer activity of novel indole-based thiosemicarbazones
Mashayekhi, Vida,Haj Mohammad Ebrahim Tehrani, Kamaleddin,Azerang, Parisa,Sardari, Soroush,Kobarfard, Farzad
, (2021/09/08)
Based on the structural elements of bioactive indole-based compounds, a series of novel 1-substituted indole-3-carboxaldehyde thiosemicarbazones were synthesized as potential antimycobacterial and anticancer agents. The derivatives were prepared via a two
Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-MET
Singh, Pankaj Kumar,Silakari, Om
, p. 163 - 170 (2018/05/22)
Secondary acquired mutation in EGFR, i.e. EGFR T790M and amplification of c-MET form the two key components of resistant NSCLC. Thus, previously published pharmacophore models of EGFR T790M and c-MET were utilized to screen an in-house database. On the ba
Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors
Chadha, Navriti,Jaggi, Ameteshar Singh,Silakari, Om
, p. 655 - 660 (2017/08/22)
Poly (ADP-ribose) polymerase (PARP-1) is a well-established nuclear protein with prominent role in signaling and DNA repair. Various clinical candidates have been identified with the role in PARP-1 inhibition. Based on the pharmacophoric features identified from previous studies and molecular docking interactions, thiazolidine-2,4-dione derivatives have been evaluated for their PARP inhibitory activity. From an in vitro assay, 5-((1-(4-isopropylbenzyl)-1H-indol-3-yl)methylene)thiazolidine-2,4-dione (16) was identified as a potent inhibitor having low micromolar inhibitory activity (IC50=0.74±0.25μM). Thus, a structure-based design approach utilized in the present study helped to identify thiazolidine-2,4-dione as a novel scaffold against PARP-1 for potential development of potent anticancer therapeutics.